Why the study?
Do antibodies against angiotensin-converting enzyme reduce blood pressure in rats with two-kidney Goldblatt hypertension?
Do antibodies against angiotensin-converting enzyme reduce blood pressure in rats with two-kidney Goldblatt hypertension?
Heterologous antibodies against ACE can effectively lower blood pressure in a rat model of renovascular hypertension, demonstrating the critical role of the renin-angiotensin system in this condition.
Answers are grounded in this paper and cite their sources.
ACE antibodies merit investigation as a hypertension therapy; leaves open translation from rodent models to clinical use.
Goat antibodies developed against pure rabbit pulmonary angiotensin-converting enzyme (peptidyl dipeptidase, EC 3.4.15.1) were administered intravenously to rats with two-kidney Goldblatt hypertension and to normotensive animals. In the hypertensive model these antibodies were associated with a sustained, immune-dependent decrease of blood pressure to normal values. A smaller, but also immune-specific, reduction of blood pressure was observed in the normotensive group. The data suggest that heterologous antibody directed against angiotensin-converting enzyme may provide a biologically specific probe for examining the contribution of the renin-angiotensin system to normal and pathologic circulatory states.
No takes yet. Share an insight, caveat, or question.
Markle et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: